Summit Client SenesTech Goes Public

Summit congratulates client SenesTech, Inc. on its IPO launch on December 8, 2016. SenesTech is the developer of an innovative technology for managing animal pest populations through fertility control as opposed to lethal methods. The Company’s first fertility control product, ContraPest®, will be marketed for use initially in controlling rat infestations. Establishing a new paradigm in rodent control, SenesTech believes its non-lethal approach is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. 

The IPO closed on December 13, 2016. Roth Capital Partners acted as sole book-running manager, and Craig-Hallum Capital Group and Aegis Capital Corp. acted as co-managers.

Summit Partner Andy Shawber led the Summit team on SenesTech's IPO.

To read more about the IPO, click here. To read more about SenesTech and ContraPest®, visit the Company's website at

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.